Literature DB >> 21944795

Primary hyperparathyroidism: how many cases are being missed?

I M Shapey1, S S Jaunoo, C Hanson, S R Jaunoo, S Thrush, A Munro.   

Abstract

INTRODUCTION: Primary hyperparathyroidism (PHPT) is a common condition (250 per million population per year) with significant associated morbidity and mortality. Surgery is the only curative option for PHPT; results from medical treatment remain disappointing. The aim of this study was to evaluate the referral patterns of patients with PHPT and identify the number of missed cases with a biochemical diagnosis of PHPT.
MATERIALS AND METHODS: All chemistries for Worcestershire were performed and analysed at the Worcestershire Royal Hospital. Patients with chronic renal failure were identified and excluded. Routes of patient referral were identified and missed cases documented. General practitioners (GPs) were contacted by letter for all patients not referred or treated. Outcomes of diagnosis and specialist assessment were recorded.
RESULTS: A total of 102 cases of PHPT were identified: 64 (62.7%) remained untreated and without a specialist referral in place, 36 (35.3%) had undergone parathyroidectomy and 2 (2.0%) were being monitored. The GP response rate was 90% (46/51). Of these, 30 (65%) were subsequently referred, 9 (20%) underwent repeat tests with a view to referral and 7 (15%) were lost to follow up.
CONCLUSIONS: A significant proportion of patients with PHPT remain in the community untreated and having not seen a specialist. All patients should be referred to a specialist for assessment and consideration of surgical treatment and follow-up. Improvements in GP education and referral systems are required if patients are to benefit.

Entities:  

Mesh:

Year:  2011        PMID: 21944795      PMCID: PMC3363079          DOI: 10.1308/003588411X13020175704352

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  17 in total

1.  Therapeutic controversies in primary hyperparathyroidism.

Authors:  S J Silverberg; J P Bilezikian; H G Bone; G B Talpos; M J Horwitz; A F Stewart
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

2.  Parathyroidectomy in the west Midlands.

Authors:  A R Ready; T Sabharawal; A D Barnes
Journal:  Br J Surg       Date:  1996-06       Impact factor: 6.939

3.  Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial.

Authors:  G Stephen Morris; Elizabeth G Grubbs; Christopher M Hearon; Swaroop Gantela; Jeffrey E Lee; Douglas B Evans; Holly M Holmes; Naifa L Busaidy; Camilo Jimenez; Nancy D Perrier
Journal:  Ann Surg       Date:  2010-05       Impact factor: 12.969

Review 4.  Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Robert Udelsman; Janice L Pasieka; Cord Sturgeon; J E M Young; Orlo H Clark
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

5.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

6.  The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical outcome study.

Authors:  Janice L Pasieka; Louise Parsons; Jean Jones
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

7.  Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism.

Authors:  Nancy D Perrier; Dave Balachandran; Jeffrey S Wefel; Camilo Jimenez; Naifa Busaidy; George S Morris; Wenli Dong; Edward Jackson; Storm Weaver; Swaroop Gantela; Douglas B Evans; Elizabeth G Grubbs; Jeffrey E Lee
Journal:  Surgery       Date:  2009-10-30       Impact factor: 3.982

Review 8.  Primary hyperparathyroidism--is mild disease worth treating?

Authors:  N J L Gittoes; M S Cooper
Journal:  Clin Med (Lond)       Date:  2010-02       Impact factor: 2.659

9.  How asymptomatic is asymptomatic primary hyperparathyroidism?

Authors:  C Hasse; H Sitter; S Bachmann; A Zielke; M Koller; C Nies; W Lorenz; M Rothmund
Journal:  Exp Clin Endocrinol Diabetes       Date:  2000       Impact factor: 2.949

Review 10.  Role of surgery in mild primary hyperparathyroidism in the elderly.

Authors:  N A Roche; A E Young
Journal:  Br J Surg       Date:  2000-12       Impact factor: 6.939

View more
  2 in total

1.  Scan-directed mini-incision focused parathyroidectomy: how accurate is accurate enough?

Authors:  I M Shapey; S Jabbar; Z Khan; J E Nicholson; R J Watson
Journal:  Ann R Coll Surg Engl       Date:  2017-02       Impact factor: 1.891

2.  Hospital care for primary hyperparathyroidism in Italy: a 6-year register-based study.

Authors:  Cristiana Cipriani; Vincenzo Carnevale; Federica Biamonte; Sara Piemonte; Jessica Pepe; Luciano Nieddu; John P Bilezikian; Salvatore Minisola
Journal:  Eur J Endocrinol       Date:  2014-07-11       Impact factor: 6.664

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.